MIAMI BEACH, Fla., September 21, 2011 — Four years ahead of scheduled human trials, Divine Skin
Inc. (DSKX) has announced the release of the first topical hair-growth treatment based on astressin-B, a
peptide newly discovered to regrow hair on bald mice. Divine Skin becomes the first biotech developer
to synthesize and commercialize the peptide for human use in a cosmetic product, to be marketed as
Spectral.F7 under the DS Laboratories brand.
“Astressin-B is a very complex peptide that is difficult to synthesize,” said Divine Skin CEO Daniel
Khesin. “So we are especially excited that the resulting product will be reasonably priced as well as
cutting-edge, considering the extraordinary development schedule and cost.”
Astressin-B sparked extensive media coverage worldwide and excitement around the biotech industry
after a clinical study, conducted by the University of California Los Angeles and the Veterans
Administration, was published in February. By applying the peptide (a protein fragment) subcutaneously
to mice that had gone bald due to overexpression of stress hormones, scientists showed that astressin-B
blocked receptors for corticotropin-releasing factor, involved in the stress response, and led to hair
regrowth. The peptide also compared favorably with minoxidil, a chemical on the market for three
“We think this technology is years ahead of its time,” continued Khesin. “It could provide significant
benefits to many of our hair-loss customers. Spectral.F7 is another direct result of our relentless
commitment to bring the latest technology to market first and always.”
Spectral.F7, a booster that can be combined with other treatments or used alone, should begin shipping
in October. It comes less than two months after Divine Skin introduced Nanoxidil, a new molecule
designed to stimulate follicles at the vertex of the scalp and surpass minoxidil for efficacy and
About Divine Skin
Divine Skin Inc. leads in the development of biotechnology for topical, nutritional, and pharmaceutical
therapies. It markets worldwide through online and specialty retailers, cosmetics wholesalers, salons,
and medical offices. The fast-growing company went public in 2009.
DS Laboratories, its flagship brand, offers high-performance topical solutions to restore growth and
radiance to hair, suppress dandruff and unwanted hair, control acne, improve hygiene, and reduce
cellulite and wrinkles. Bioavailability is enhanced through encapsulation (www.dslaboratories.com).
The Sigma Skin brand sells through upscale retailers like Neiman Marcus in the United States and
Harvey Nichols in the United Kingdom. The topical products address hair loss and other signs of aging
Polaris Research Laboratories makes high-potency minoxidil-based hair-growth formulas
The Pure Guild offers purity with performance: Botanical compounds proven effective in clinical trials
are extracted without industrial solvents or damaging heat and are sold through premium retailers
NutraOrigin blends nutritional supplements that address the health concerns expressed by consumers,
including fatigue, headache, obesity, mobility, menopause, erectile dysfunction, and others. In clinical
trials for the US government, its Omega line proved to enhance mental function (www.nutraorigin.com).
IIIIIIIIIIIIIIIIIII barrack yard I westport I county mayo I ireland I tel: 098-26200 I fax: 098-26202 I www.mercuryfreeentistry.eu | ishskoinfo@ gmail.com | Evelien Van Amerongen (founder, holistic dentist) CONSENT TO TREATMENT I voluntarily consent to receive dental and complimentary that all services must be paid for at the time of the visit , health care services
Sucht - Rauchen - Nikotinsucht Medikamentenabhängigkeit/sucht Süchtig sein heißt, dass suchterzeugende Mittel nicht mehr abgesetzt werden können, ohne psychische oder körperliche Entzugserscheinungen zu bekommen. Entzugserscheinungen können sein: Nervosität, Zittern, Schweißausbrüche, Gedankenfixation auf das Suchtmittel, Denkhemmung, Halluzinationen, Delirium, Bauchkrämpfe, Üb